Skip to main
NRCIB
NRCIB logo

National Research (NRCIB)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy National Research (NRCIB) Stock

About National Research (NRCIB)

National Research Corp. engages in the provision of analytics and insights that facilitate patient, employee, and customer retention. It offers solutions that address specific needs around market insight, experience, transparency, and governance for healthcare providers, payers, and other healthcare organizations. The company was founded by Michael D. Hays in 1981 and is headquartered in Lincoln, ...read more
Market cap
Today's volume
Revenue (TTM)$139.1M
Avg. daily volume
EBITDA (TTM)$34.6M
Open
Price / earnings ratio
Today's range
Debt / equity559.15x
52 week range
5 year debt / equity
Beta (LTM)
Interest coverage9.86x
Dividend & yield— (—)
Current ratio0.53x
Ex-dividend date
Next earnings
Dividend payable date

Frequently Asked Questions (FAQ)

How to buy NRCIB stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in NRCIB stock

    Navigate to the Explore page. Then, type NRCIB into the search bar. When you see NRCIB stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased NRCIB stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Buy National Research (NRCIB) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.